Daybreak provides a fully at-home solution for diagnosing and treating sleep apnea using an FDA-cleared sleep test and a custom-fit mandibular advancement device. This approach eliminates the need for sleep labs, offering a non-invasive alternative to CPAP machines, resulting in improved sleep quality and reduced snoring for users.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional sleep apnea diagnosis requires in-lab testing, which can be inconvenient and costly. CPAP machines, a common treatment, can be uncomfortable and lead to compliance issues, while surgery presents a more invasive alternative.
Solution
Daybreak offers a fully at-home solution for sleep apnea, encompassing diagnosis and treatment. The process begins with an FDA-cleared at-home sleep test, eliminating the need for a sleep lab. If diagnosed with sleep apnea, customers receive a custom-fit mandibular advancement device (MAD), a discreet oral appliance that gently moves the lower jaw forward to open the airway. This non-invasive alternative to CPAP machines aims to improve sleep quality and reduce snoring. The entire process is doctor-directed, and the company handles insurance verification and claim filing.
Target Audience
Individuals experiencing sleep apnea symptoms, those seeking a CPAP alternative, and people who prefer the convenience of at-home medical solutions are the primary customers.
Features
- FDA-cleared at-home sleep test for convenient diagnosis
- Custom-fit mandibular advancement device (MAD) as a CPAP alternative
- Doctor-directed treatment and support throughout the process
- Online portal to track progress
- Insurance verification and claim filing assistance
- 3-year guarantee on the Daybreak Device